Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

Interferons and interleukins are pleiotropic agents (they cause a variety of effects), so the therapeutics were studied in a wide variety of diseases, including anti-infective, antineoplastic and ...

Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

PD-1 and PD-L1 immune checkpoint inhibitors (ICIs) for treating advanced cancer were associated with an increased risk of new ...

A total of 135,230 patients with clinical stage III or IV cancer (mean age, 62.94 years; 45.1% women) who received antineoplastic medications between January 2019 and June 2021 were included in the ...

The long-term response rate for zanubrutinib was better than ibrutinib in patients with relapsed/refractory chronic ...

OCT for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to ...

In recent years, our cumulative understanding of a number of scientific breakthroughs in the fields of tumor biology and genomics has translated into novel antineoplastic therapeutic approaches.

You can access a range of bibliographical databases with your NHS OpenAthens account. Sign in to see what you can access. You can access bibliographic databases from the providers' websites. For ...

Pregnancy. Nursing mothers. Increased risk of methemoglobinemia when concurrently exposed to nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials ...